Monoclonal Antibody Treatment Mobile Outpatient Services

The State of Nevada, Department of Administration Purchasing Division, on behalf of the Department of Health and Human Services (DHHS), Division of Public and Behavioral Health (DPBH), has issued a Request for Qualifications (RFQ) to procure monoclonal antibody treatment mobile or fixed outpatient services for the treatment of SARS-CoV-2/COVID-19 across the state of Nevada. The RFQ seeks proposals from qualified vendors to provide staffing, equipment, supplies, and other necessary services to operate monoclonal antibody treatment sites at locations across Nevada, with the capacity to serve sites with 10 to 100 clients per day. The contract term is for four years, subject to Board of Examiners approval, with a rolling award solicitation having an initial deadline of September 1, 2021 and a final deadline of December 31, 2021. The State reserves the right to accept and evaluate additional proposals after the initial deadline. Vendors must meet various mandatory minimum requirements and critical items, including insurance, background, staff qualifications, and financial information, to be considered for award.

The RFQ does not specify any set-aside designations or restrictions on the types of organizations that can respond. The State intends to award multiple contracts for this opportunity. The Cost Proposal must include per treatment and per day not-to-exceed rates, as the Contractor will seek reimbursement from the Centers for Medicare & Medicaid Services (CMS) for eligible individuals. The RFQ does not provide information on any incumbent vendors or current contractors, or the available budget for this procurement.